Charles Elliott Sigal - May 22, 2023 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Sung Lee, Attorney-in-Fact
Stock symbol
VIR
Transactions as of
May 22, 2023
Transactions value $
$0
Form type
4
Date filed
5/24/2023, 02:33 PM
Previous filing
May 19, 2023
Next filing
Jul 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Award $0 +6.03K +61.63% $0.00 15.8K May 22, 2023 Direct
holding VIR Common Stock 10K May 22, 2023 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Award $0 +12.1K $0.00 12.1K May 22, 2023 Common Stock 12.1K $25.74 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 By Sigal Family Investments, LLC